Status:
COMPLETED
Folic Acid Supplementation in Gambian Primigravidae
Lead Sponsor:
London School of Hygiene and Tropical Medicine
Collaborating Sponsors:
Medical Research Council Unit, The Gambia
Department of State for Health and Social Welfare, The Gambia
Conditions:
Malaria
Eligibility:
FEMALE
Phase:
PHASE3
Brief Summary
Supplementation with folic acid and iron is recommended for pregnant women in order to prevent them from developing anemia. In malaria endemic areas of Africa, the World Health Organization (WHO) now ...
Detailed Description
Objective The objective of this study is to determine if administration of folic acid to pregnant women at the same time as sulfadoxine-pyrimethamine (SP) is given to prevent malaria interferes with ...
Eligibility Criteria
Inclusion
- Primigravid pregnancy \> 15 weeks
- Residence in study area
- Informed consent
Exclusion
- Any serious underlying illness.
- History of adverse reaction to sulfonamides
Key Trial Info
Start Date :
July 1 2002
Trial Type :
INTERVENTIONAL
End Date :
January 1 2004
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT00120822
Start Date
July 1 2002
End Date
January 1 2004
Last Update
January 12 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical Research Council, Laboratories
Banjul, The Gambia, PO Box 273